These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 2048838)

  • 21. Short-term effects of inhalative tiotropium/formoterol/budenoside versus tiotropium/formoterol in patients with newly diagnosed chronic obstructive pulmonary disease requiring surgery for lung cancer: a prospective randomized trial.
    Bölükbas S; Eberlein M; Eckhoff J; Schirren J
    Eur J Cardiothorac Surg; 2011 Jun; 39(6):995-1000. PubMed ID: 20970351
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Management of chronic obstructive pulmonary disease: moving beyond the asthma algorithm.
    Gordon E; Lazarus SC
    J Allergy Clin Immunol; 2009 Nov; 124(5):873-80; quiz 881-2. PubMed ID: 19895979
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mono- and combination therapy of long-acting bronchodilators and inhaled corticosteroids in advanced COPD.
    Ohar JA; Donohue JF
    Semin Respir Crit Care Med; 2010 Jun; 31(3):321-33. PubMed ID: 20496301
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tiotropium bromide, a new long-acting antimuscarinic bronchodilator: a pharmacodynamic study in patients with chronic obstructive pulmonary disease (COPD). Dutch Study Group.
    Maesen FP; Smeets JJ; Sledsens TJ; Wald FD; Cornelissen PJ
    Eur Respir J; 1995 Sep; 8(9):1506-13. PubMed ID: 8575576
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bronchial hyperresponsiveness: the need for a distinction between hypersensitivity and excessive airway narrowing.
    Sterk PJ; Bel EH
    Eur Respir J; 1989 Mar; 2(3):267-74. PubMed ID: 2659385
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anticholinergic bronchodilators in obstructive airway disease.
    Karpel JP
    J Assoc Acad Minor Phys; 1991; 2(3):118-22. PubMed ID: 1839720
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of allergy and nonspecific airway hyperresponsiveness in the pathogenesis of chronic obstructive pulmonary disease.
    O'Connor GT; Sparrow D; Weiss ST
    Am Rev Respir Dis; 1989 Jul; 140(1):225-52. PubMed ID: 2665587
    [TBL] [Abstract][Full Text] [Related]  

  • 28. COPD management. Part I. Strategies for managing the burden of established COPD.
    Jenkins C
    Int J Tuberc Lung Dis; 2008 Jun; 12(6):586-94. PubMed ID: 18492322
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Are chronic obstructive pulmonary disease (COPD) and asthma different diseases?
    Magnussen H; Richter K; Taube C
    Clin Exp Allergy; 1998 Nov; 28 Suppl 5():187-94; discussion 203-5. PubMed ID: 9988466
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Early intervention with inhaled corticosteroids in subjects with rapid decline in lung function and signs of bronchial hyperresponsiveness: results from the DIMCA programme.
    den Otter JJ; van Schayck CP; Folgering HT; van den Boom G; Akkermans RP; van Weel C
    Eur J Gen Pract; 2007; 13(2):89-91. PubMed ID: 17534745
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Corticosteroid reversibility in COPD is related to features of asthma.
    Chanez P; Vignola AM; O'Shaugnessy T; Enander I; Li D; Jeffery PK; Bousquet J
    Am J Respir Crit Care Med; 1997 May; 155(5):1529-34. PubMed ID: 9154853
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [FEV1 after three years of observation in patients with bronchial asthma and patients with chronic obstructive pulmonary disease].
    Zagdańska R; Grzelewska-Rzymowska I
    Pneumonol Alergol Pol; 2005; 73(2):142-7. PubMed ID: 16756143
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Management 1997 of chronic obstructive pulmonary disease. Working Group of the Swiss Society of Pneumology.
    Leuenberger P; Anderhub HP; Brändli O; Keller R; Knoblauch A; Kuhn M; Perruchoud AP; Rochat T; Russi E; Villiger B; Zellweger JP
    Schweiz Med Wochenschr; 1997 May; 127(18):766-82. PubMed ID: 9167240
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhaled corticosteroids in chronic obstructive pulmonary disease: a review.
    Telenga ED; Kerstjens HA; Postma DS; Ten Hacken NH; van den Berge M
    Expert Opin Pharmacother; 2010 Feb; 11(3):405-21. PubMed ID: 20102305
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacotherapy of chronic obstructive pulmonary disease.
    Borron W; deBoisblanc BP
    J La State Med Soc; 1998 Dec; 150(12):596-600. PubMed ID: 9926698
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Favorable effects of rehabilitation in patients with CARA].
    Cox NJ; Hendriks J; Binkhorst RA; van Herwaarden CL
    Ned Tijdschr Geneeskd; 1991 Jun; 135(22):987-91. PubMed ID: 2062395
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interaction between parenchyma and airways in chronic obstructive pulmonary disease and in asthma.
    Pride NB; Ingram RH; Lim TK
    Am Rev Respir Dis; 1991 Jun; 143(6):1446-9. PubMed ID: 2048835
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bronchodilator reversibility in COPD: the roguish but harmless little brother of airway hyperresponsiveness?
    Hansen EF; Vestbo J
    Eur Respir J; 2005 Jul; 26(1):6-7. PubMed ID: 15994382
    [No Abstract]   [Full Text] [Related]  

  • 39. Pharmacology of airway inflammation in asthma and COPD.
    Caramori G; Adcock I
    Pulm Pharmacol Ther; 2003; 16(5):247-77. PubMed ID: 12877818
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Isocapnic hyperventilation for measuring airway hyperresponsiveness in asthma and in chronic obstructive pulmonary disease.
    O'Byrne PM; Ramsdale EH; Hargreave FE
    Am Rev Respir Dis; 1991 Jun; 143(6):1444-5. PubMed ID: 1904701
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.